← Nazad


Chirlaque MD



Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017;77:140-52. [Šekerija M]

Autori: Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larranaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R, EUROCARE-5 Working Group
Godina: 2017

Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396-404]. Gynecol Oncol. 2017;147(3):725. [Šekerija M]

Autori: Matz M, Coleman MP, Carreira H, Salmeron D, Chirlaque MD, Allemani C, CONCORD Working Group
Godina: 2017

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2). Gynecol Oncol. 2017;144(2):396-404. [Šekerija M]

Autori: Matz M, Coleman MP, Carreira H, Salmeron D, Chirlaque MD, Allemani C, CONCORD Working Group
Godina: 2017

Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405-413]. Gynecol Oncol. 2017;147(3):726. [Šekerija M]

Autori: Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C, the CONCORD Working Group
Godina: 2017

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol. 2017;144(2):405-13. [Šekerija M]

Autori: Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C, the CONCORD Working Group
Godina: 2017